Search

everythinglearnresearchcommunity

for

Search:↓

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Weight loss can cause temporary hair loss, especially in women and older adults.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Low Vitamin D and its receptors might be linked to chronic hair loss in women.

Women with telogen effluvium have lower levels of VEGF, which may contribute to their hair loss.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Telogen effluvium is a condition that causes temporary hair loss.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

A girl lost her hair due to being given the wrong medication because of a pharmacy's computer error.

Mouse skin can produce and process serotonin, with variations depending on hair cycle, body location, and mouse strain.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Vitamin D Receptor is needed for hair growth in mice but not for skin stem cell maintenance.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The research created a model to understand human hair growth cycle, which can help diagnose and treat hair growth disorders and test potential hair growth drugs.

Bovine milk fats applied to mouse skin can promote hair growth similar to known hair growth treatments.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

KDML105 bran extract may help with hair growth and prevent hair loss.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.